Clinical Research Directory
Browse clinical research sites, groups, and studies.
In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients
Sponsor: Assistance Publique Hopitaux De Marseille
Summary
The aim of this study is to describe the tumor microenvironment of solid tumors and to understand the changes induced by anti-cancer treatments, particularly those developed by Innate Pharma. Innate Pharma is a biotechnology company which discovers and develops therapeutic antibodies that exploit the innate immune system to improve cancer treatment. Thanks to this study, it will be possible to correlate clinical and immunological characteristics with the patient\'s clinical features. The analyses generated will contribute to the design and improvement of innovative therapeutic antibodies acting on the immune system
Official title: In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
640
Start Date
2025-04-30
Completion Date
2028-04-30
Last Updated
2025-02-14
Healthy Volunteers
No
Interventions
blood collection
Blood sampling is performed during Scrrening / visit 1 for patients enrolled in cohort 1, cohort 2 and cohort 3
tissue specimen collection
In Cohort 1- patients with solid tumor undergoing surgery, fresh tissue specimen is collected during surgery
Locations (1)
Hopital Timone enfants - plateforme d'Immunoprofiling
Marseille, France